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Edited by Jesus AvilaAbstract Tau exon 10 (E10) splicing is a crucial event in its
developmental change of tau isoform and tauopathy. To investi-
gate the splicing mechanism, we isolated and compared mouse
tau genomic sequence with human sequence. We identiﬁed a
new element in mouse intron 10 (I10) to suppress E10 splicing,
which was located just after the stem–loop region previously pro-
posed in human sequence and found to potentially form another
stem–loop. Human I10 with a mutation (+29G to A) causing a
decreased E10 splicing was also predicted to form similar double
stem–loop, suggesting that this element is universally involved in
regulation of E10 splicing.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Tau is one of the microtubule-associated proteins (MAPs)
that play a role in promoting the polymerization and stabil-
ization of neuronal microtubules and is involved in both
the maintenance of the neuronal cytoskeleton and axonal
transport [1]. Human tau is encoded by a single gene
(TAU) on chromosome 17 from which six isoforms are pro-
duced in the adult brain by alternative splicing of exons 2,
3 and 10 [2,3]. Tau exon 10 (E10) encodes the second micro-
tubule-binding domain, and alternative splicing of this exon
results in isoforms with three (E10) or four (E10+) microtu-
bule-binding domains referred to as three-repeat tau (3R-tau)
and four-repeat tau (4R-tau), respectively [4]. 4R-tau binds
microtubules more avidly than 3R-tau due to its additional
microtubule-binding domain encoded with E10 [5,6]. In hu-
man brains, only 3R-tau is expressed in the fetal stage, while
both 3R-tau and 4R-tau are expressed in a ratio of approxi-
mately 1:1 in the adult stage [2,7]. In contrast, rodent brains
express only 3R-tau in fetal and neonatal stages and only 4R-
tau in the adult stage [3,7,8]. Some mutations of the TAU
gene found in frontotemporal dementia with parkinsonism
linked to chromosome 17 (FTDP-17) have been shown to
aﬀect alternative splicing of E10 and to thereby increase or
decrease the ratio of 3R-tau to 4R-tau [9,10].*Corresponding author. Fax: +81 6 6645 3922.
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doi:10.1016/j.febslet.2004.11.090Thus, as splicing of mouse E10 is diﬀerent from human E10,
the comparison of two genomic sequences is expected to pro-
vide a useful information. Genomic fragments were isolated
from mouse genome libraries and compared with human se-
quence. E10 and adjacent intron 10 (I10) sequence was rela-
tively well conserved but a new element was identiﬁed in
mouse I10 to have a potency to form a unique secondary struc-
ture. Such an element was identiﬁed in mouse genome but it
may play a universal role in E10 splicing.2. Materials and methods
2.1. Human and mouse tau genomic constructs
Human tau441 and tau410 cDNA constructs were previously pre-
pared with the mammalian expression vector pECE [11]. Human and
mouse tau genomic fragments were ampliﬁed from human and
mouse genome libraries of BD GenomeWalker Kits #638901
and #638902, respectively (Clontech, CA). The PCR primers for
the human fragment containing tau E9 and the ﬂanking downstream
intron, E10, and the ﬂanking upstream and downstream introns, or
E11 and the ﬂanking upstream intron were 5 0-GAT-
GGTAAAACGAAGATCGCCACACC-3 0 and 5 0-ATGAATTCGC-
CAGCCACTCTCACCTTCCCGCCTCCCGGCTGGTGCTTCA-3 0,
5 0-AAGAATTCCAGTGCTGGCAGCAATGTGGTG-30 and 5 0-TT-
TTTGCGGCCGCGGTGTGAGGGTCGATG-3 0, or 5 0-TTGGAT-
CCTTGCTCATTCTCTCTCCTCCTCTCTCATCTCCAGGTGCA-
AATAGTCTACAAACCAG-3 0 and 5 0-AGGCAGACACCTCGT-
CAGCTAGCGT-3 0, respectively. With PCR products containing
E9, E10, or E11, tau iEi10 was constructed to contain the human
tau gene encoding E1-9, the ﬁrst 18 nucleotides and the last 3.0
kb of I9, E10, the ﬁrst 3.0 kb and the last 38 nucleotides of I10,
and E11-13. To prepare a human–mouse chimeric construct, tau
iEi10 hm, both human construct tau iEi10 and mouse construct
hm1 (see Fig. 2) were digested with AseI and FspI, and the resulting
fragments were exchanged and incorporated again.
DNA sequences and secondary structures of human and mouse tau
genes were analyzed with the DNA Analyzing Software Package ver.5
(GENETYX, Tokyo).
2.2. Cell culture and exon trapping assay of exon 10 splicing
COS-7 (monkey kidney), HEK293 (human kidney) and Neuro2a
(mouse neuroblastoma) cells were grown in Dulbeccos modiﬁed
Eagles medium containing 2 mM of L-glutamine (Invitrogen, CA)
supplemented with 10% fetal calf serum. Cells were transiently trans-
fected with each of the tau DNA constructs using LipofectAMINE
reagent (Invitrogen). The exon trapping assay was performed with
the splicing vector pSPL3b according to the previous report [12].2.3. Oligonucleotide probing assay and RNase protection assay
To conﬁrm the predicted secondary structure of mouse I10, two
oligoRNAs were synthesized. OligoRNA WT (5 0-AUG-
AGGUGUGCUGCAGCCUUUGCUGUAACAAGUGUCAU-3 0)
represents the mouse I10 second stem–loop element, and oligoRNAblished by Elsevier B.V. All rights reserved.
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GUCUA-30) was designed to avoid a hairpin structure but to have
the same A, U, G, C content as oligoRNA WT.
Both oligoRNAs were heated at 95 C for 5 min in Pyrobest buﬀer
(20 mM Tris–HCl buﬀer (pH 8.3), 10 mMKCl, 6 mM (NH4)2SO4, and
1 mMMgCl2) and quickly cooled down on ice so as to retain their lin-
ear conformation followed by mixing with loading dye containing 95%
formamide and applied onto 15% polyacrylamide gels containing
8 M urea. After electrophoresis, the gels were stained with ethidium
bromide.
For the oligonucleotide probing assays, oligoRNA WT and MT
were heated at 95 C for 5 min in Pyrobest buﬀer and allowed to form
their native secondary structure by cooling down slowly to 25 C. Oli-
goRNAs were mixed with loading dye without formamide and applied
onto 15% polyacrylamide gels without urea and electrophoresed. Oli-
goRNAs were transferred onto Hybond-N+ membranes (Amersham
Pharmacia Biotech) followed by incubation in hybridization buﬀer
(5· SSC (83.25 mM sodium citrate, 83.25 mM NaCl)/7% SDS/50%
formamide/2% blocking reagent (Roche Diagonostics)/0.1% N-lau-
roylsarcosine/50 mM sodium phosphate/50 lg/ml salmon sperm
DNA (Invitrogen)) at 37 C for 2 h. The resultant membranes were
further incubated with a digoxigenin (DIG)-labeled oligoRNA probe
(5 0-DIG-CAGCACACCUCAU-30) in hybridization buﬀer at 37 C
overnight followed by washing with 2· SSC/0.1% SDS at RT, twice
with 0.1· SSC/0.1% SDS at 37 C, and then with washing buﬀer
[0.3% Tween 20, 100 mM maleic acid (pH 7.5), and 150 mM NaCl]
at RT, and blocked in a solution containing 1% blocking reagent,
100 mM maleic acid (pH 7.5) and 150 mM NaCl at RT for 30 min.
After two washes of the membranes with washing buﬀer, hybridized
oligoRNA probe was detected with peroxidase-conjugated anti-DIG
antibody (1:1000) (Roche Diagonostics) and ECL plus (Amersham
Pharmacia Biotech).Fig. 1. Genome sequence and secondary structure of mouse tau exon 10 an
sequenced (Accession Nos. AB072732 and AB086984). Exon 10 (E10) and it
box shows tau E10. (B) Tau iEi10 is the human construct composed of human
sequences of I10, and E11-13. Tau iEi10 hm is the human–mouse chimeric co
the mouse AseI–FspI fragment. The open and closed boxes represent human a
COS-7, HEK293 and Neuro2a cells transfected with the DNA constructs. Tau
as molecular markers representing 3R-tau (E10) and 4R-tau (E10+), respe
the bar of the mean and standard deviation, respectively, of at least three i
mouse E10 and I10 were predicted with a hairpin analysis program (GENETY
(E) The secondary structure of human E10 and I10 was predicted to be the sin
(D) and (E) show mouse ISM-like and human ISM sequences, respectively3. Results and discussion
3.1. Genomic sequences of mouse E10 and I10
Mouse tau genomic fragments were isolated and sequenced
(see GenBank Accession Nos. AB072732 and AB086984 for
their sequence information). As shown in Fig. 1A, the se-
quence corresponding to E10 and the ﬂanking introns of inter-
est were arranged for comparison with the human sequence.
We found that E10 was highly conserved with 95% sequence
homology between mouse and human, while intron 10 (I10)
was less conserved with 68% homology. Thus, mouse I10 ap-
pears to play a signiﬁcant role in E10 splicing, using a diﬀerent
regulatory mechanism from human I10.
3.2. Existence of a sequence regulating E10 splicing in mouse I10
and its predicted secondary structure
To examine mouse E10 splicing, human or mouse sequences
of E10 and the ﬂanking I10 were constructed with human E1-
9, I9 and E11-13 sequences in the mammalian expression vec-
tor pECE as illustrated in Fig. 1B. Human tau construct (tau
iEi10) showed 1:1 for 4R-tau and 3R-tau, respectively, while
the human–mouse chimeric tau construct (tau iEi10 hm)
showed the predominant expression of 3R-tau in three diﬀer-
ent cells (Fig. 1C). This result clearly suggested the suppression
activity in mouse sequence particularly in intron 10 (I10). We
examined the second structure of mouse E10 and the ﬂankingd the ﬂanking introns. (A) The TAU genomic clone was obtained and
s adjacent introns were compared with the human sequence. The open
E1-9, short 5 0- and long 3 0-sequences of I9, E10, long 5 0- and short 3 0-
nstruct that was made by replacing the human AseI–FspI fragment with
nd mouse-derived sequences, respectively. (C) RT-PCR products from
410 and tau441 constructs provide PCR bands with 428 bp and 521 bp
ctively. The relative E10 inclusion for each construct was calculated as
ndependent transfection experiments. (D) The secondary structures of
X, Inc.). Two stem–loop structures were proposed for mouse sequence.
gle stem–loop structure initially proposed [10]. The shadowed boxes in
[13,14].
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tures that were consecutively positioned in tandem fashion.
The ﬁrst stem–loop structure was similar to the human version
previously proposed [10], while the second stem–loop structure
was observed only in the mouse sequence. The juxtaposition of
these two stem–loop structures suggests that they cooperate in
E10 splicing (Fig. 1D).3.3. The second stem–loop element in mouse I10 has a regulatory
sequence
Mouse-derived sequence was further examined with the exon
trapping assay using the splicing vector pSPL3b to see the ef-Fig. 2. Identiﬁcation of mouse regulatory region for tau E10 splicing
by exon trapping assay. To identify the regulatory region for tau E10
splicing in mouse E10 and the ﬂanking introns, four constructs were
prepared with the splicing vector pSPL3b and subjected to an exon
trapping assay with COS-7 cells. (A) Constructs contain E10 and
about 400 bp of each of the ﬂanking upstream and downstream introns
of human and mouse tau, respectively. The open and closed boxes
represent human and mouse-derived sequences, respectively. (B) The
relative E10 inclusion was presented according to Fig. 1. The relative
E10 inclusion was represented as the bar of the mean and standard
deviation, respectively, of at least three independent transfection
experiments. (C) The secondary structure of human I10 with +29 (G to
A) mutation of FTDP-17 was predicted with a hairpin analysis
program (GENETYX, Inc.). The human ISM sequence is indicated by
a shadowed box.fect of this second stem–loop sequence on E10 splicing. For
this purpose, four constructs were made by replacement of hu-
man sequence with that of mouse as shown in Fig. 2A. Beside
well-known other regulating elements such as an exon splicing
enhancer (ESE), an intron splicing silencer (ISS) or an intron
splicing modulator (ISM) [13,14], the mouse-speciﬁc second
stem–loop sequence was found to have a suppressing activity
(Fig. 2B).
Recently, a novel mutation (+29 (G to A)) in tau I10 was
found in a pedigree with FTDP-17 in which 3R-tau levels were
increased [15]. This mutation is localized in the second stem–
loop element, where it is in a downstream of the sequence in-
volved in the stem–loop structure model [10] and the linear se-
quence model [13,14]. Hence, we examined its eﬀect on E10
splicing with the same exon trapping assay (Fig. 2A). As
shown in Fig. 2B, this +29 (G to A) mutation produced a de-
crease in the rate of E10 splicing relative to the wild construct,
which is in good agreement with an increase of 3R-tau expres-
sion in FTDP-17 with this mutation. It was noteworthy that
the sequence containing this mutation was predicted to form
a new small hairpin structure (Fig. 2C) similar to the double
stem–loop structures in mouse I10. Such a stem–loop structure
was ﬁrst proposed and well explains the eﬀect of the mutations
of FTDP-17 [10]. It does not seem that the present second
stem–loop structure element is solely or independently func-
tional on E10 splicing, since it was located at the downstream
of the ﬁrst stem–loop structure sequence or of the ISS/ISM se-
quence and positioned in the face of the ISM sequence as seenFig. 3. Double-stranded characteristics of the putative secondary
stem–loop structure. (A) Two oligoRNA were synthesized to conﬁrm
the predicted secondary structure of mouse I10. A DIG-labeled
oligoRNA probe was designed to hybridize with the common 13 base
sequence of two oligoRNA. (B) These two oligoRNAs showed the
same mobility in polyacrylamide gels under a denaturing condition
(urea+), but oligoRNA WT moved faster than oligoRNA MT under
non-denaturing conditions (urea). (C) In the oligonucleotide probing
assays, oligoRNAs were separated under non-denaturing conditions
and transferred onto Hybond-N+ membranes and incubated with a
DIG-labeled oligoRNA probe. OligoRNA MT bound almost exclu-
sively to the probe.
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gested this sequence was involved, even indirectly, in E10
splicing.
3.4. The putative second stem–loop structure shows
double-stranded characteristics
To provide physicochemical evidence for the second stem–
loop structure, we designed two synthetic oligoRNAs.
OligoRNA WT contained the second stem–loop sequence
and oligoRNA MT was designed to avoid any hairpin struc-
ture but to have the same A, U, G, C content as oligoRNA
WT (Fig. 3A). As shown in Fig. 3B, these two oligoRNAs
show almost the same mobility in a polyacrylamide gel under
denaturing conditions, as would be expected from their molec-
ular weight. In contrast, oligoRNAWTmoved faster due to its
compact structure than oligoRNA MT under non-denaturing
condition. This was further conﬁrmed by hybridization exper-
iment with DIG-labeled oligoRNA probe that was designed to
contain the complementary sequence to the ﬁrst 13 bases of the
two oligoRNAs. As shown in Fig. 3C, oligoRNA MT, but not
oligoRNA WT, showed a positive signal, suggesting that olig-
oRNA WT was masked by forming a hairpin structure and
was not exposed to hybridize with the DIG-probe as illustrated
in Fig. 3A.
We still do not know if such steric structure exists in vivo but
the longer intron than previously expected is undoubtedly in-
volved in E10 splicing and tau iEi10 (Fig. 1) could be useful
as a tool construct for research on tau development and
FTDP-17 pathogenesis.
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